The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Editas Medicine, Sarepta Therapeutics and Beam Therapeutics

Published on October 15, 2021

The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Editas Medicine, Sarepta Therapeutics and Beam Therapeutics

Continue reading on website
Other news

3 Lord Abbett Mutual Funds You Should Buy Right Now

October 15, 2021
Below we share with you three top-ranked Lord Abbett mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy).

5 Ways to Become a Top Performer at Any Company

October 15, 2021
How to become a standout employee, as told by a CEO.